A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Retrospective analysis on efficacy of convalescent plasma in acute respiratory distress syndrome due to COVID-19
São Paulo Medical Journal
Coronavirus disease 2019 (COVID-19) is an ongoing global health threat. However, currently, no standard therapy has been approved for the disease. To evaluate the clinical effectiveness of convalescent plasma (CP) in patients with acute respiratory distress syndrome (ARDS) due to COVID-19. Retrospective study conducted at Kayseri City Education and Research Hospital, Kayseri, Turkey. The case group consisted of adult patients (> 18 years) with ARDS due to COVID-19 who received CP in combinationdoi:10.1590/1516-3180.2021.0200.r1.03052021 pmid:34468633 fatcat:yzi5cwqogncz3jm23qttgnsngm